Pomerantz LLP Announces Securities Class Action Lawsuit Against Nektar Therapeutics, Inc. – NKTR
NEW YORK CITY, NY / ACCESS Newswire / March 20, 2026 / Pomerantz LLP announces that a class action lawsuit has been filed against Nektar Therapeutics ("Nektar" or the "Company") (NASDAQ:NKTR) and certain officers.â?¯â?¯ The class action, filed in the United States District Court for the Northern District of California, and docketed under 26-cv-01951, is […]